These results describe the study products, not a retail gummy. The practical decision is straightforward: choose a clearly labeled product only after checking its cannabinoid amounts, and skip full-spectrum products if a THC drug test could affect your job, license, or other high-stakes outcome.
What did the human CBD studies for pain find?
The 2025 Nature Medicine trial tested VER-01, a full-spectrum Cannabis sativa extract, in 820 adults with chronic low back pain. During its double-blind 12-week phase, 394 participants received VER-01 and 426 received placebo. In participants with a neuropathic-pain component, the extract group also had a larger reduction on the neuropathic pain symptom inventory.
The trial continued beyond those 12 weeks in open-label and continuation phases. Adverse events were more frequent with VER-01 than placebo in the blinded phase (83.3% versus 67.3%), and the report describes most as mild to moderate and temporary.
A separate 2024 randomized trial followed 54 healthy adults for 12 weeks. Participants took a liquid CBD product at 50 mg twice daily, or placebo. The healthy-adult CBD trial reported lower foundational pain index scores in the CBD group than in the placebo group over the intervention.
| Study | Who and how long | What was used | Measured result |
|---|---|---|---|
| Nature Medicine, 2025 | 820 adults with chronic low back pain; 12-week blinded phase | VER-01 full-spectrum cannabis extract | Mean pain change −1.9 vs −1.3 with placebo; difference −0.6 points |
| JISSN, 2024 | 54 healthy adults; 12 weeks | Liquid CBD, 50 mg twice daily | Foundational pain index was lower in the CBD group over the intervention |
What does full spectrum CBD mean?
“Full spectrum” is a product-label term for a hemp extract that keeps a wider mix of hemp compounds instead of CBD alone. For a gummy buyer, the essential label question is whether the formula includes THC and how many milligrams appear in one serving.
CBD isolate is intended to contain CBD without the broader cannabinoid profile. Broad-spectrum products are generally formulated to retain other hemp compounds while removing THC. Full spectrum can include THC, so it is a different choice from a THC-free formula even when the front label emphasizes CBD.
In a 2025 controlled human laboratory study, 15 healthy adults took a patented full-spectrum oral product containing CBD, CBDA, THC, THCA, and minor cannabinoids. The active sessions used average CBD doses of 41.1 mg, 73.4 mg, and 134.5 mg, with average THC doses of 2.2 mg, 3.9 mg, and 7.2 mg. At the two higher dose levels, participants reported small-to-moderate subjective drug effects; the highest dose also impaired working-memory performance. Read the full-spectrum oral study for the exact formulation and dose details.
Can full spectrum CBD make you high or affect a drug test?
It can affect both decisions because full-spectrum products can contain THC. The controlled oral study found subjective intoxication at its highest tested dose, despite a mean THC dose of 7.2 mg, and THC metabolites were often detectable 48 hours after dosing.
For a fuller label-based decision path, see this site’s cbd labels and drug tests. The site’s CBD drug-test guide also explains the questions to settle before a workplace or licensing screen.
A batch-specific certificate of analysis can show the cannabinoid panel for the product you are considering. If a negative result is essential, the most conservative route is to avoid cannabinoid products until the testing requirement has passed.
What should you not mix with CBD?
CBD can affect how the liver processes medicines. Before taking a CBD gummy, speak with a clinician or pharmacist if you use prescription medicines, particularly blood thinners, seizure medicines, or medicines where a changed blood level could matter. That conversation is particularly important if you take blood thinners, seizure medicines, or another medicine for which changed blood levels could matter.
For cancer care, see the National Cancer Institute’s cannabis and cannabinoids PDQ. Bring the package or its cannabinoid panel to the oncology team or pharmacist so they can consider the full medication list and treatment plan.
A 2025 case report indexed by the National Library of Medicine described a 26-year-old who developed nausea, vomiting, marked tachycardia, a heart-conduction change, and lactic acidosis after ingesting 40 mg of CBD gummies; symptoms resolved with supportive care. The CBD gummy case report shows why concerning symptoms after taking a gummy warrant medical care.
How are CBD gummies labeled and dosed in these studies?
The pain-related human studies here used a named full-spectrum extract or a liquid CBD product, rather than a standard retail gummy. That matters because the delivery form, cannabinoid profile, and dose were part of each study design.
| Study product | Form | CBD amount | Other relevant cannabinoids |
|---|---|---|---|
| Healthy-adult CBD product | Liquid with medium-chain triglyceride oil | 50 mg/mL; 1 mL twice daily | CBD product |
| Human laboratory product | Soft gel | 41.1–134.5 mg average active-session CBD doses | CBDA, THC, THCA, and minor cannabinoids |
For a gummy, check the CBD milligrams per gummy, the serving size, the THC amount per serving, the ingredient list, and a batch-specific report before you decide. The site’s CBD pain-relief guide helps put pain-related CBD questions in context.
Where does FDA-approved CBD fit in?
For information about cannabis research, see the FDA’s cannabis research guidance. For a CBD gummy, the label and formulation are important details to review before purchase.
How do you choose a full spectrum CBD gummy for pain?
Start with the label rather than a “best” claim. Choose a gummy only when you can identify the CBD amount per serving, the THC amount, the complete ingredient list, and the matching batch report. Golden Touch Fusion CBD Gummies are one example; the site’s golden touch fusion cbd gummies reviews covers its listed ingredients, price, and safety questions.
A gummy can be convenient because the serving is pre-portioned, while a label check remains the key step for CBD and THC exposure.
Before you order
- Check whether a workplace, licensing, court, or other program requires a negative THC result.
- Ask a clinician or pharmacist before combining CBD with prescription medicines, chemotherapy, or a complex medication routine.
- Match the package to a batch-specific cannabinoid report and confirm THC per serving.
- Use the product’s own ingredient list to check for food allergens or ingredients you avoid.
- For a sleep or anxiety question, choose a page focused on that decision rather than assuming a pain study answers it.
Disclosure: HealthDataConsortium.org may earn a commission from qualifying product links.
By HealthDataConsortium.org Research Team
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.
